Results 211 to 220 of about 46,848 (253)

Tolerability of Atypical Antipsychotics

Drug Safety, 2000
Atypical antipsychotics are expected to be better tolerated than older antipsychotics because of their lower propensity to cause certain adverse effects. All atypical drugs have been shown to cause fewer acute extrapyramidal symptoms (EPS) than a standard typical agent (usually haloperidol) and some (clozapine, sertindole and quetiapine) appear to ...
Stanniland, C, Taylor, D
openaire   +3 more sources

Dosing Atypical Antipsychotics

CNS Spectrums, 2008
The task of prescribing, dosing, and switching antipsychotics is generally characterized by a process of trial and error, often resulting in suffering from side effects and/or lack of response while searching for the optimum treatment. Clinical trials often inaccurately predict optimum doses and titration schedules, leaving prescribers without precise ...
Andrew, Cutler, Sara, Ball, Stephen M, Stahl   +2 more
openaire   +2 more sources

Atypical antipsychotics in the elderly

International Journal of Psychiatry in Clinical Practice, 2001
Although their primary purpose is to treat psychosis, antipsychotics are commonly prescribed for the elderly to treat the behavioural disturbances and agitation associated with dementia. Such use is controversial. Atypical antipsychotics cause fewer extrapyramidal sideeffects than the older drugs in younger adults, but the evidence base for their ...
openaire   +2 more sources

Muscarinic mechanisms of antipsychotic atypicality

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2003
The interactions of the atypical antipsychotic drugs (APD) clozapine, olanzapine, risperidone, quetiapine and ziprasidone with muscarinic receptors were reviewed. Only clozapine and olanzapine have marked affinity for muscarinic receptors in radioligand binding studies; however, the affinity of these compounds is considerably lower than classical ...
Frank P, Bymaster, Christian C, Felder, Eleni, Tzavara, George G, Nomikos, David O, Calligaro, David L, Mckinzie   +5 more
openaire   +2 more sources

Drug metabolism and atypical antipsychotics

European Neuropsychopharmacology, 1999
The introduction of the atypical antipsychotics clozapine, risperidone, olanzapine, quetiapine and sertindole for the treatment of schizophrenia has coincided with an increased awareness of the potential of drug-drug interactions, particularly involving the cytochrome P450 (CYP) enzymes.
T I, Prior, P S, Chue, P, Tibbo, G B, Baker   +3 more
openaire   +2 more sources

Atypical antipsychotics.

Psychiatric medicine, 1991
This chapter discusses the clinical application of the currently studied atypical antipsychotics in the United States and abroad. A description of the proposed mode of action of these medications and the most relevant studies is included.
D, Holland, M D, Watanabe, R, Sharma
openaire   +1 more source

Atypical antipsychotics and diabetes

Irish Journal of Psychological Medicine, 2002
Reeves, S, Howard, R
openaire   +2 more sources

The Beef With Atypical Antipsychotics

American Journal of Psychiatry, 2002
Justin, Sauer, Robert, Howard
openaire   +2 more sources

Atypical Antipsychotics and the Pharmacology of Olanzapine

Journal of the American Psychiatric Nurses Association, 1997
Atypical antipsychotics present exciting opportunities to improve the quality of life for many individuals who are experiencing the debilitating impact of schizophrenia, a syndrome with complex symptom presentations and unclear cause. In the past the antipsychotic efficacy was thought to correlate with the degree of dopamine blockade; this hypothesis ...
openaire   +1 more source

Varying and "atypical" indications for atypical antipsychotics

Psychopharmacology, 2003
Barbui C., Tansella M., Garattini S.
openaire   +2 more sources